StayCurrentMD
Ovarian Tumors
Everything in the library about ovarian tumors — built automatically from the recorded discussions that name it
Educational content from recorded physician discussions — not medical advice. Always talk to your child's care team about your child's situation.
Content of this collection
Case-Based Learning
2 items
Pediatric Ovarian Tumors Video Podcast
Listen →
An interactive discussion between Dr. Ponsky and Dr. Rescorla about the management of ovarian tumors in pediatric patients. Dr. Frederick Rescorla is surgeon-in-chief at Riley Children's Hospital, Anna Olivia Healey Professor of Pediatric S
podcast34:06 · Sep 2018
Ovarian Tumors Video Podcast
Listen →
An interactive discussion between Dr. Ponsky and Dr. Rescorla about the management of ovarian tumors in pediatric patients. Dr. Frederick Rescorla is surgeon-in-chief at Riley Children's Hospital, Anna Olivia Healey Professor of Pediatric S
podcast34:06 · Dec 2020
In-Depth Reviews
1 item
Ovarian Tumors with Dr. Roshni Dasgupta
Watch →
There is a lot to know when it comes to ovarian tumors! Here, Dr. Roshni Dasgupta, from Cincinnati Children's, breaks down the highlights for us.
Host: Brittany Levy
video · Sep 2022
Summaries and takeaways+ Show
The doctors in this collection+ Show
All expert statements+ Show
Every expert statement below comes from the recorded discussions, with its speaker and moment.
Ovarian Tumors Video Podcast
Predominantly cystic ovarian masses have approximately 3-4% malignancy risk
epidemiologicalFred Rescorla4:03 ↗
Heterogeneous ovarian masses have 15-20% malignancy rate
epidemiologicalFred Rescorla4:25 ↗
Solid ovarian masses have over 25% malignancy risk
epidemiologicalFred Rescorla4:32 ↗
Approximately 10% or less of all pediatric ovarian tumors are malignant
epidemiologicalFred Rescorla5:03 ↗
Among malignant pediatric ovarian tumors, germ cell tumors predominate at greater than 50%, possibly up to 80% in some series
epidemiologicalFred Rescorla5:18 ↗
Among benign pediatric ovarian tumors, mature teratoma comprises at least half of cases
epidemiologicalFred Rescorla5:43 ↗
Immature teratoma accounts for approximately 10-15% of benign ovarian tumors
epidemiologicalFred Rescorla5:51 ↗
In a study of 20 stage III ovarian tumors, 5 were stage III only because peritoneal fluid was positive for malignant cells; without checking washings they would have been considered stage I with likely higher recurrence
host_summaryFred Rescorla8:10 ↗
For ovarian tumor surgery, six oncologic steps are recommended: peritoneal washings, tumor removal, contralateral ovary inspection (biopsy only if abnormal), omental assessment (remove if adherent to tumor), peritoneal cavity assessment for implants, and retroperitoneal lymph node palpation (remove only if enlarged)
guidelineFred Rescorla10:40 ↗
Contralateral ovarian biopsy is now recommended only if the ovary appears abnormal, not routinely
guidelineFred Rescorla10:54 ↗
For large predominantly cystic ovarian masses with normal markers, the malignancy risk is much less than 1%
epidemiologicalFred Rescorla15:57 ↗
Pre-menarchal girls have a higher risk of ovarian torsion compared to post-menarchal adolescents
host_summaryFred Rescorla26:57 ↗
Oophoropexy is recommended for pre-menarchal girls with ovarian torsion or for patients with recurrent torsion of the same ovary
host_summaryFred Rescorla27:12 ↗
Stage I malignant germ cell ovarian tumors have 96% overall survival
epidemiologicalFred Rescorla30:20 ↗
Stage I germ cell tumors managed with observation alone have approximately 50% relapse rate
epidemiologicalFred Rescorla30:33 ↗
Salvage rate for relapsed stage I germ cell tumors is nearly 100%
epidemiologicalFred Rescorla30:43 ↗
Stage II and III germ cell ovarian tumors have 97% survival with chemotherapy
epidemiologicalFred Rescorla30:55 ↗
Stage IV germ cell ovarian tumors have approximately 80% overall survival
epidemiologicalFred Rescorla31:15 ↗
Stage IV germ cell tumors in patients under 11 years have 92% survival
epidemiologicalFred Rescorla31:23 ↗
Stage IV germ cell tumors in patients over 11 years have 60% survival
epidemiologicalFred Rescorla31:33 ↗
Standard chemotherapy for intermediate-risk germ cell tumors is platinum, etoposide, and bleomycin
guidelineFred Rescorla32:00 ↗
Metastatic sites in stage IV germ cell tumors do not require biopsy if clearly metastatic on imaging; they are followed with imaging
clinicalFred Rescorla32:13 ↗
Black, torsed ovaries should not be removed; detorsion alone is appropriate
clinicalFred Rescorla32:32 ↗
Ovarian-preserving procedures (partial oophorectomy) are appropriate for cystic or mixed cystic-solid masses; oophorectomy is reserved for solid tumors
clinicalFred Rescorla32:44 ↗
Alpha-fetoprotein (AFP) is the primary tumor marker for pediatric ovarian tumors; HCG is unlikely to be elevated in young children but is checked routinely
clinicalFred Rescorla3:25 ↗
Chest CT is required for staging of malignant ovarian tumors and should be obtained preoperatively
guidelineFred Rescorla20:53 ↗
For malignant ovarian tumors amenable to resection, primary surgical resection is preferred even if metastases are present
clinicalFred Rescorla21:31 ↗
Fallopian tube preservation during oophorectomy is optional; the tube should be preserved if not encased by tumor but can be removed if adherent or difficult to separate
clinicalFred Rescorla21:42 ↗
Peritoneal washings are the main factor that can upstage an otherwise apparent stage I tumor to a higher stage
clinicalFred Rescorla22:48 ↗
Pediatric surgeons manage primarily germ cell tumors (chemo-responsive) while gynecologic oncologists manage primarily epithelial tumors, explaining differences in surgical approach including lymph node dissection
clinicalFred Rescorla23:20 ↗
What's new+ Show